As of 2026-07-05, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (482.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -200050.2%.
The range of the Relative Valuation is (454.94) - (526.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 23.3x | 20.5x |
| Forward P/E multiples | 19.7x - 22.8x | 21.2x |
| Fair Price | (454.94) - (526.54) | (482.08) |
| Upside | -188795.5% - -218488.7% | -200050.2% |
| Date | P/E |